Publicaciones en las que colabora con María Páez De la Cadena Tortosa (13)
2020
-
Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial
Scientific Reports, Vol. 10, Núm. 1
2017
-
Evaluation of an automated commercial ELISA method for calprotectin determination in pleural fluid
Clinical Chemistry and Laboratory Medicine
-
Highly sensitive marker panel for guidance in lung cancer rapid diagnostic units
Scientific Reports, Vol. 7
-
Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis
BMC Cancer, Vol. 17, Núm. 1
2015
-
Pretreatment levels of the serum biomarkers CEA, CYFRA 21–1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients
SpringerPlus, Vol. 4, Núm. 1
-
Serum calprotectin, CD26 and EGF to establish a panel for the diagnosis of lung cancer
PLoS ONE, Vol. 10, Núm. 5
2014
-
Evaluation of pleural effusion sCD26 and DPP-IV as diagnostic biomarkers in lung disease
Scientific Reports, Vol. 4
2013
-
Levels of PEDF in pleural effusions from lung adenocarcinoma and benign disease patients
Disease Markers, Vol. 34, Núm. 6, pp. 425-430
2012
-
Calprotectin: A novel biomarker for the diagnosis of pleural effusion
British Journal of Cancer, Vol. 107, Núm. 11, pp. 1876-1882
2010
-
Validation of PEDF as a potential biomarker for NSLC
Proteómica: revista de la Sociedad Española de Proteómica, Núm. 5, pp. 61-62
2009
-
Análisis protométrico del derrame pleural para la obtención de nuevos marcadores de cáncer de pulmón
Investigación: cultura, ciencia y tecnología, Núm. 2, pp. 20-31
-
In the search of early stages biomarkers for non small cell lung cancer
Proteómica: revista de la Sociedad Española de Proteómica, Núm. 3, pp. 155-155
-
Proteomic approach to improve the diagnosis of malignant pleural effusions
Proteómica: revista de la Sociedad Española de Proteómica, Núm. 3, pp. 150-150